Company Profile
Updated: 17-SEP-09DOR BioPharma Inc.
Public Company, Headquarters Location
29 Emmons Dr., Ste. C-10, Princeton, NJ 08540-5919, United States
(609)538-8200, (609)452-6467 fax, http://www.dorbiopharma.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufactures pharmaceuticals to treat cancer, development of oral and mucosal drug-delivery system for vaccines, allergens, and other therapies.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax™ and Other Rapidly Acting Vaccines.
Vaccine Weekly; 12/2/2009; 865 words; Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company...include SRI International, Health Research Inc, Battelle Memorial Institute, Nanotherapeutics...
Other News To Note.(Amgen Inc. licensing agreement with ImmunoGen Inc.)(Inovio Biomedical Corp.)(Pfizer Inc.)(United States. Food and Drug Administration)
BIOWORLD Today; 11/23/2009; 1684 words; ...of America in Atlanta. o Pfizer Inc., of New York, received FDA approval...treatment of schizophrenia. o Soligenix Inc., of Princeton, N.J., formerly known as DOR BioPharma Inc., has formed a consortium to develop...
News and FDA Updates for BD (NYSE:BDX), Soligenix, Inc. (OTC:SNGX).
M2 Presswire; 11/23/2009; 995 words; ...completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based Company...platforms. On 11/20/09, Soligenix, Inc. (OTC:SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company...
Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines.
PR Newswire; 11/20/2009; 1961 words; ...PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX...the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology...SRI International, Health Research Inc, Battelle Memorial Institute, Nanotherapeutics...
Soligenix Reports Third Quarter 2009 Financial Results.
PR Newswire; 11/13/2009; 1805 words; ...SNGX) , formerly known as DOR BioPharma, Inc., a late-stage biotechnology...change to Soligenix, Inc. from DOR BioPharma, Inc. -- The completion of a...Soligenix), formerly known as DOR BioPharma, Inc., is a late-stage biopharmaceutical...
Recent News Articles
- DayTradersDigest.com Profiles Vivakor, Inc. & DOR BioPharma, Inc.
M2 Presswire - September 30, 2009 - Boston, MA -- Form4Oracle: Insider Trading Report: DOR BioPharma, Inc. (DORB.OB).
M2 Presswire - September 29, 2009 - Profiles Vivakor, Inc. & DOR BioPharma, Inc.
M2 Presswire - September 21, 2009 - Profiles HearAtLast Holdings, Inc. & DOR BioPharma, Inc.
M2 Presswire - September 03, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning